Displaying items by tag: department of neurology

Anthony Nicholas, M.D., associate professor in the Department of Neurology at the University of Alabama at Birmingham, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
A new UAB clinic can predict risk for developing Alzheimer’s disease and offer strategies to reduce that risk.
As part of its ongoing Science, Communication and Innovation talks, Lucas Pozzo-Miller will speak about Rett syndrome.
A new NIH grant could allow researchers to better predict risk factors for patients using blood-thinners by examining the influence of genes, lifestyle, clinical factors and environment.
Parkinson’s disease awareness is highlighted with official recognition from Alabama and the city of Birmingham in April.
Learn about Lou Gehrig’s disease at the second UAB Neuroscience Café at the Hoover Library.
UAB has teamed with the Michael J. Fox Foundation to look for genetic biomarkers for Parkinson’s disease.
Neuroscience Café serves healthy portions of fascinating topics in the field of neuroscience at 6:30 p.m. on the third Monday of every month.
Researchers at UAB show that high-intensity strength training improves mobility, mood and overall quality of life for Parkinson’s patients.
CNET promotes the discovery of novel treatments for neurodegenerative disorders, teaches scientists and clinicians about these diseases, and facilitates the application of these discoveries to the clinical care of patients.
Gel form of a medication for Parkinson’s disease speeds response time over traditional pills.
This group, newly established as an AES committee, is charged with promoting and tracking progress in areas targeted as potential epilepsy benchmarks by NINDS.

The program supports and cultivates students interested in Parkinson’s related research projects.

The network has the largest group of well-characterized pediatric MS cases in the world.

Bebin is co-director of the UAB Tuberous Sclerosis Clinic and a founding member of the TSC Clinical Research Consortium.

UAB Neurology adds to evidence that massive, second-wave reaction kills nerve cells.

Page 11 of 13